Sign In
Buy TMO
$473.95
-8.13 (-1.69%)
At Close: Jun 03, 2026
mRNA Biotechs - Long-Term Value Risks Abound
06:20am, Thursday, 28'th Aug 2025
mRNA vaccine companies are overhyped post-pandemic, facing scientific, operational, and regulatory headwinds that limit long-term investment appeal. Scientific and business risks, including delivery c
Thermo Fisher (TMO) Up 1.8% Since Last Earnings Report: Can It Continue?
12:35pm, Friday, 22'nd Aug 2025
Thermo Fisher (TMO) reported earnings 30 days ago. What's next for the stock?
Thermo Fisher Scientific Opens Manufacturing Center of Excellence Site in North Carolina
04:56pm, Thursday, 21'st Aug 2025
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today announced the grand opening of its innovative manufacturing center of excellence facility in
Why Thermo Fisher Scientific Stock Was Topping the Market Today
04:22pm, Tuesday, 19'th Aug 2025
An analyst launched coverage of Thermo Fisher Scientific (TMO 2.15%) after market close on Monday, and the stock was experiencing a little pop the following day as a result. On Tuesday, it closed more
Thermo Fisher Positioned As Biopharma's Partner Of Choice
03:38pm, Tuesday, 19'th Aug 2025
Could Thermo Fisher Scientific Inc. TMO be the unsung hero of the biopharma sector's future? While its stock performance has recently lagged, analysts are betting on a major turnaround driven by strat
TMO Receives FDA Approval for Oncomine Dx Target Test
10:15am, Friday, 15'th Aug 2025
Thermo Fisher secures FDA approval for its Oncomine Dx Target Test to identify NSCLC patients eligible for HERNEXEOS treatment.
Final Trades: Toast, Transdigm, Thermo Fisher and Amazon
03:44pm, Wednesday, 13'th Aug 2025
The Investment Committee give you their top stocks to watch for the second half.
Thermo Fisher: Growth Acceleration And Margin Expansion Should Drive The Upside
11:20pm, Monday, 11'th Aug 2025
Revenue growth is accelerating, led by pharma/biotech momentum and bioproduction demand. The medium-term margin outlook is positive with cost cuts, AI-driven efficiencies, and lapping of tariff headwi
Thermo Fisher Receives FDA Approval for NGS-Based Companion Diagnostic for New Non-Small Cell Lung Cancer Treatment
08:30am, Monday, 11'th Aug 2025
CARLSBAD, Calif.--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, has received approval from the U.S. Food and Drug Administration (FDA) for its Oncomine Dx Target Test
Thermo Fisher: The Rerating Is Just Getting Started - Buy
04:09pm, Friday, 08'th Aug 2025
Thermo Fisher is emerging from a challenging period with solid fundamentals, strong cash flow, and renewed growth, making it undervalued by the market. Recent earnings showed organic growth, margin ex
Thermo Fisher Q2: Pharma And Biotech Gains Offset By Weak Academic And Gov't Markets
01:31pm, Wednesday, 06'th Aug 2025
I reiterate my Buy rating on Thermo Fisher Scientific Inc., with a fair value estimate of $568 per share, reflecting its undervalued stock price. Q2 FY25 results showed early signs of market recovery,
Investing in Thermo Fisher (TMO)? Don't Miss Assessing Its International Revenue Trends
10:17am, Monday, 04'th Aug 2025
Explore how Thermo Fisher's (TMO) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.
Trade tracker: Bill Baruch buys Thermo Fisher
01:08pm, Friday, 01'st Aug 2025
Bill Baruch, founder and president at Blue Line Capital, joins CNBC's “Halftime Report” to explain why he's buying Thermo Fisher here.
Thermo Fisher Posts 3% Q2 Rise
02:20pm, Tuesday, 29'th Jul 2025
Thermo Fisher Posts 3% Q2 Rise
Thermo Fisher Scientific Showcases Diagnostics Solutions Designed to Meet Evolving Global Healthcare Demands at ADLM 2025
09:18am, Monday, 28'th Jul 2025
CHICAGO--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, showcases its innovations in improving clinical and diagnostic laboratory efficiency and workflow optimization
